124 related articles for article (PubMed ID: 12581766)
1. CD8(+) T cells induce graft vascular occlusion in a CD40 knockout donor/recipient combination.
Raisky O; Spriewald BM; Morrison KJ; Ensminger S; Mohieddine T; Obadia JF; Yacoub MH; Rose ML
J Heart Lung Transplant; 2003 Feb; 22(2):177-83. PubMed ID: 12581766
[TBL] [Abstract][Full Text] [Related]
2. Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation.
Ensminger SM; Spriewald BM; Sorensen HV; Witzke O; Flashman EG; Bushell A; Morris PJ; Rose ML; Rahemtulla A; Wood KJ
J Immunol; 2001 Jul; 167(1):532-41. PubMed ID: 11418692
[TBL] [Abstract][Full Text] [Related]
3. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
4. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
[TBL] [Abstract][Full Text] [Related]
5. Intragraft interleukin-4 mRNA expression after short-term CD154 blockade may trigger delayed development of transplant arteriosclerosis in the absence of CD8+ T cells.
Ensminger SM; Spriewald BM; Witzke O; Morrison K; van Maurik A; Morris PJ; Rose ML; Wood KJ
Transplantation; 2000 Sep; 70(6):955-63. PubMed ID: 11014649
[TBL] [Abstract][Full Text] [Related]
6. Impact of both donor and recipient strains on cardiac allograft survival after blockade of the CD40-CD154 costimulatory pathway.
van Maurik A; Wood KJ; Jones ND
Transplantation; 2002 Sep; 74(5):740-3. PubMed ID: 12352896
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing interleukin-4 prevents transplant arteriosclerosis mediated by indirect pathway T cells under CD40-CD154 costimulation blockade.
Spriewald BM; Ensminger SM; Bushell A; Wood KJ
Transplantation; 2008 Dec; 86(11):1615-21. PubMed ID: 19077898
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
[TBL] [Abstract][Full Text] [Related]
9. CD4+ and CD8+ T cell priming for contact hypersensitivity occurs independently of CD40-CD154 interactions.
Gorbachev AV; Heeger PS; Fairchild RL
J Immunol; 2001 Feb; 166(4):2323-32. PubMed ID: 11160289
[TBL] [Abstract][Full Text] [Related]
10. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
11. IL-12 augments CD8+ T cell development for contact hypersensitivity responses and circumvents anti-CD154 antibody-mediated inhibition.
Gorbachev AV; DiIulio NA; Fairchild RL
J Immunol; 2001 Jul; 167(1):156-62. PubMed ID: 11418644
[TBL] [Abstract][Full Text] [Related]
12. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy.
van Maurik Av; Herber M; Wood KJ; Jones ND
J Immunol; 2002 Nov; 169(10):5401-4. PubMed ID: 12421913
[TBL] [Abstract][Full Text] [Related]
14. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway.
Guo Z; Meng L; Kim O; Wang J; Hart J; He G; Alegre ML; Thistlethwaite JR; Pearson TC; Larsen CP; Newell KA
Transplantation; 2001 May; 71(9):1351-4. PubMed ID: 11403253
[TBL] [Abstract][Full Text] [Related]
15. In situ expression of CD40, CD40L (CD154), IL-12, TNF-alpha, IFN-gamma and TGF-beta1 in murine lungs during slowly progressive primary tuberculosis.
Mogga SJ; Mustafa T; Sviland L; Nilsen R
Scand J Immunol; 2003 Sep; 58(3):327-34. PubMed ID: 12950679
[TBL] [Abstract][Full Text] [Related]
16. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen.
van Maurik A; Fazekas de St Groth B; Wood KJ; Jones ND
J Immunol; 2004 Feb; 172(4):2163-70. PubMed ID: 14764682
[TBL] [Abstract][Full Text] [Related]
17. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
[TBL] [Abstract][Full Text] [Related]
18. Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice.
Corbascio M; Mahanty H; Osterholm C; Qi Z; Pearson TC; Larsen CP; Freise CE; Ekberg H
Transplantation; 2002 Jul; 74(1):35-41. PubMed ID: 12134096
[TBL] [Abstract][Full Text] [Related]
19. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
Zhai Y; Meng L; Gao F; Busuttil RW; Kupiec-Weglinski JW
J Immunol; 2002 Oct; 169(8):4667-73. PubMed ID: 12370407
[TBL] [Abstract][Full Text] [Related]
20. CD8+ T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade.
Ensminger SM; Witzke O; Spriewald BM; Morrison K; Morris PJ; Rose ML; Wood KJ
Transplantation; 2000 Jun; 69(12):2609-12. PubMed ID: 10910284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
